Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

LIFE Study - Limiting Chronotropic Incompetence for Pacemaker Recipients

Phase 4

Completed

Conditions: Bradycardia

First Posted Date: 2005-09-07

Last Posted Date: 2017-05-18

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1500

Registration Number: NCT00146861

REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance

Phase 4

Completed

Conditions: Arrhythmia

First Posted Date: 2005-09-07

Last Posted Date: 2017-02-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1500

Registration Number: NCT00146822

PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy

Phase 4

Completed

Conditions: Heart Failure

First Posted Date: 2005-09-07

Last Posted Date: 2011-12-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1742

Registration Number: NCT00146848

Locations: 🇺🇸
The Cleveland Clinic Hospital, Cleveland, Ohio, United States

CRT RENEWAL Registry

Completed

Conditions: Heart Failure

First Posted Date: 2005-09-07

Last Posted Date: 2010-08-18

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1000

Registration Number: NCT00146874

ULTRA Study for Pacemaker Patients

Phase 4

Completed

Conditions: Bradycardia

First Posted Date: 2005-08-23

Last Posted Date: 2007-07-10

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 950

Registration Number: NCT00133289

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Phase 3

Completed

Conditions: Overactive Bladder

Interventions: Device: bion

First Posted Date: 2005-08-19

Last Posted Date: 2013-11-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 118

Registration Number: NCT00131573

Locations: 🇺🇸
Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸
The Department of Urology, Stanford University Medical Center, Stanford, California, United States
🇺🇸
Milestone Medical Research, Englewood, Colorado, United States

and more 8 locations

WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation

Phase 2

Completed

Conditions: Atrial Fibrillation
Stroke

Interventions: Device: WATCHMAN Left Atrial Appendage Closure Technology
Drug: Warfarin

First Posted Date: 2005-08-12

Last Posted Date: 2015-05-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 800

Registration Number: NCT00129545

Locations: 🇺🇸
Advanced Cardiac Specialists, Gilbert, Arizona, United States
🇺🇸
Arizona Arrhythmia, Scottsdale, Arizona, United States
🇺🇸
Foundation for Cardiovascular Medicine, La Jolla, California, United States

and more 59 locations

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

Phase 3

Conditions: Coronary Artery Disease

Interventions: Device: Polymer-based Paclitaxel-Eluting TAXUS Express2-SR Stent
Procedure: Coronary Artery Bypass Surgery

First Posted Date: 2005-06-21

Last Posted Date: 2010-06-23

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1800

Registration Number: NCT00114972

Locations: 🇺🇸
Mercy General Hospital, Sacramento, California, United States
🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Florida Cardiovascular Research, Atlantis, Florida, United States

and more 103 locations

Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter

Phase 3

Completed

Conditions: Atrial Flutter

First Posted Date: 2005-06-07

Last Posted Date: 2011-02-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 160

Registration Number: NCT00113178

Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation

Phase 3

Terminated

Conditions: Atrial Fibrillation

First Posted Date: 2005-05-23

Last Posted Date: 2016-01-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 200

Registration Number: NCT00111488

Locations: 🇺🇸
Scripps Memorial/ Kaiser Permanente, La Jolla, California, United States
🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

and more 18 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy